In focus · trending topic

CRISPR

35 stories · following the connections

Editas Medicine to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

By Nasdaq OMXMay 8, 2018, 12:02 PM UTC

Editas Medicine Announces First Quarter 2018 Results and Update

By Nasdaq OMXMay 3, 2018, 8:02 PM UTC

Editas Medicine to Host Conference Call Discussing First Quarter 2018 Corporate Update and Results

By Nasdaq OMXApr 26, 2018, 8:01 PM UTC

Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska

By Nasdaq OMXApr 20, 2018, 12:00 PM UTC

Taconic Biosciences Launches New Inflammatory Bowel Disease Models

By Nasdaq OMXApr 19, 2018, 12:00 PM UTC

Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform

By Nasdaq OMXMar 15, 2018, 4:00 PM UTC

Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update

By Nasdaq OMXMar 6, 2018, 9:01 PM UTC

Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2017 Corporate Update and Results

By Nasdaq OMXFeb 27, 2018, 9:01 PM UTC